TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Decreased Dolutegravir and Efavirenz Concentrations With Preserved Virological Suppression in Patients With Tuberculosis and Human Immunodeficiency Virus Receiving High-Dose Rifampicin.

Christine Sekaggya-Wiltshire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.